Interferon beta

This page covers all Interferon beta drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-beta receptor (IFNAR), Interferon beta receptor (IFNBR), Interferon alpha/beta receptor.

Targets

Interferon-beta receptor (IFNAR) · Interferon beta receptor (IFNBR) · Interferon alpha/beta receptor

Marketed (5)

• Interferon beta-1a (Avonex) · Biogen · Immunology
  Interferon beta-1a activates interferon signaling pathways to modulate immune responses and reduce inflammatory activity in the central nervous system.
• Interferon beta-1a (Rebif) · Merck KGaA, Darmstadt, Germany · Immunology / Neurology
  Interferon beta-1a activates interferon signaling pathways to modulate immune responses and reduce inflammatory activity in the central nervous system.
• low immunogenic interferon-beta-1a · Biogen · Immunology
  Low immunogenic interferon-beta-1a activates interferon-beta signaling pathways to modulate immune responses and reduce inflammation in autoimmune diseases.
• Betaferon/Betaseron · Bayer · Immunology/Neurology
  Betaferon is interferon beta-1b, which activates immune cells and reduces inflammatory responses in the central nervous system to slow disease progression.
• Betaseron · Bayer Healthcare Pharms · Immunology
  Betaseron works by binding to the interferon alpha/beta receptor, which helps to reduce inflammation and slow disease progression in multiple sclerosis.

Phase 3 pipeline (1)

• BG9418 (interferon beta-1a) · Biogen · Immunology
  BG9418 is interferon beta-1a, which activates interferon signaling pathways to modulate immune responses and reduce inflammation.